Clinical trial
5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age…
NCT00120523 · MEDA Pharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00120523 |
|---|---|
| Title | 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis |
| Official title | Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age With Mild to Moderate Atopic Dermatitis |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Topical corticosteroids |
| Enrollment | 2,418 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Jul 18, 2005 |
| Last update posted | Feb 11, 2022 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: